Profile data is unavailable for this security.
About the company
Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in novel life sciences and bio-technology companies through Food and Drug Administration (FDA) approved clinical trials. The Company identifies, acquires and advances relatively de-risked clinical stage assets through clinical development and commercialization. The Company is exploring to expand its drug development pipeline through acquisitions and partnerships. The Company, through its subsidiary, SkinJect, Inc., is focused on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers. SkinJect is a novel, minimally invasive treatment for common forms of non-melanoma skin cancer, basal cell and squamous cell carcinoma.
- Revenue in CAD (TTM)0.00
- Net income in CAD-8.02m
- Incorporated2008
- Employees--
- LocationMedicus Pharma Ltd217 Queen Street West, Suite 401TORONTO M5V 0R2CanadaCAN
- Phone+1 (905) 681-1925
- Fax+1 (905) 681-1925
- Websitehttps://medicuspharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nurexone Biologic Inc | 0.00 | -4.97m | 32.32m | 8.00 | -- | 91.63 | -- | -- | -0.1127 | -0.1127 | 0.00 | 0.0054 | 0.00 | -- | -- | -- | -146.66 | -213.78 | -294.38 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0105 | -- | -- | -- | 55.45 | -- | -- | -- |
| Avicanna Inc | 22.07m | -7.25m | 32.77m | 38.00 | -- | -- | -- | 1.48 | -0.0808 | -0.0808 | 0.2477 | -0.0055 | 1.12 | 3.07 | 12.26 | 580,708.40 | -36.83 | -67.17 | -282.36 | -167.73 | 47.29 | 46.36 | -32.86 | -368.82 | 0.3163 | -10.44 | 0.1834 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -5.06m | 33.74m | -- | -- | 5.96 | -- | -- | -0.1289 | -0.1289 | 0.00 | 0.1241 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipharm Labs Corp | 36.99m | -13.61m | 34.42m | 166.00 | -- | 0.6889 | -- | 0.9305 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
| Simply Better Brands Corp | 109.02m | -33.11m | 35.10m | -- | -- | -- | -- | 0.322 | -0.4616 | -0.4616 | 1.54 | -0.0684 | 2.84 | 6.79 | 22.87 | -- | -86.36 | -63.90 | -460.44 | -215.48 | 58.69 | -- | -30.37 | -29.46 | 0.298 | -8.19 | 1.65 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| Medicus Pharma Ltd | 0.00 | -8.02m | 35.62m | -- | -- | 32.30 | -- | -- | -1.25 | -1.25 | 0.00 | 0.0681 | 0.00 | -- | -- | -- | -539.96 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -7.90 | 0.00 | -- | -- | -- | -300.86 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 37.97m | -- | -- | -- | -- | 51.54 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -17.21m | 38.48m | 5.00 | -- | -- | -- | -- | -1.11 | -1.11 | 0.00 | -0.6896 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Charlotte's Web Holdings Inc | 79.55m | -41.66m | 38.61m | 164.00 | -- | 0.6046 | -- | 0.4853 | -0.2716 | -0.2716 | 0.5182 | 0.4052 | 0.3668 | 1.07 | 27.08 | 485,053.90 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Medexus Pharmaceuticals Inc | 157.99m | 8.03m | 39.71m | 98.00 | 4.45 | 0.9818 | 2.48 | 0.2514 | 0.3637 | 0.3637 | 7.27 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,612,120.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Immunoprecise Antibodies Ltd | 23.68m | -14.26m | 40.54m | 102.00 | -- | 0.8137 | -- | 1.71 | -0.4147 | -0.4147 | 0.6874 | 1.39 | 0.2939 | 5.25 | 6.76 | 170,046.20 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Decibel Cannabis Company Inc | 115.96m | -1.77m | 40.99m | -- | -- | 0.8854 | 30.59 | 0.3535 | -0.0045 | -0.0045 | 0.2739 | 0.1129 | 0.817 | 1.51 | 7.66 | -- | -1.25 | -3.55 | -2.04 | -5.19 | 36.10 | 38.83 | -1.53 | -7.13 | 0.3685 | 1.21 | 0.5122 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
Data as of May 21 2024. Currency figures normalised to Medicus Pharma Ltd's reporting currency: Canadian Dollar CAD
